Nandrolone Decanoate

DECOVIB

COMPOSITION
Nandrolone Decanoate50 MG | 25MG
SPECIFICATION
FORMINJECTABLE
PACKING1’s
PACKING TYPE
MRP130 | 85

DESCRIPTION

C18 steroid with androgenic and anabolic properties. It is generally prepared from alkyl ethers of estradiol to resemble testosterone but less one carbon at the 19 position. It is a schedule III drug in the U.S.

SIDE EFFECTS

Postmenopausal osteoporosis
Anemia with renal insufficiency
Debilitating illness

INDICATION

For the treatment of refractory deficient red cell production anemias, breast carcinoma, hereditary angioedema, antithrombin III deficiency, fibrinogen excess, growth failure and Turner’s syndrome. It is also indicated in the prophylaxis of hereditary angioedema.